BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 6, 2012
View Archived Issues
Roche reflects on accomplishments of second quarter 2012
Read More
Sirolimus reduces skin cancer occurrence in renal transplant recipients
Read More
Pol I inhibitor shows anticancer potency in vitro and in vivo
Read More
MEK inhibitor improves survival in METRIC trial
Read More
Kyowa Hakko Kirin presents overview of first half 2012
Read More
Researchers at Novartis disclose novel beta-secretase inhibitors
Read More
Sanofi updates R&D progress of second quarter 2012
Read More
New sodium channel blockers designed by Pfizer
Read More
Korean group prepares new GPR119 receptor ligands
Read More
Bionor Pharma presents new candidate vaccines
Read More
Belgian scientists divulge novel antiviral alphabodies
Read More
Beta Pharma patents novel protein kinase inhibitors
Read More
GSK confirms submissions for dabrafenib and trametinib
Read More
New technique offers alternative to gene therapy
Read More
Zaltrap approved in U.S. for cancer indication
Read More
ACT advances stem cell trial for dry AMD
Read More
FDA assigns PDUFA action date for enzalutamide NDA
Read More
Ono kicks off first-in-human study of peptide-cocktail vaccine
Read More
Pluristem reports second successful compassionate use of PLX cells
Read More
Daiichi Sankyo presents overview of first quarter fiscal 2012
Read More
UCB reviews events of first half 2012
Read More
U.S. university and Novartis form global alliance for anticancer T-cell immunotherapies
Read More
NIH awards grant to support study of Immuron candidate drug for steatohepatitis
Read More
Marina Biotech grants Novartis license for CRN technology
Read More